I reported previously (twice) about Israeli Glaucoma- treatment developer IOPtima. Now China’s Kanghong is partnering IPOtima’s to market its glaucoma laser surgery system, IOPtiMate, in Asia, which has some of the world’s highest rates of blindness from glaucoma. https://www.caixinglobal.com/2018-04-03/quick-take-china-to-see-more-of-israeli-glaucoma-treatment-101230131.html

Israel’s BioLight has announced the first sale of XLVision Sciences’ IOPtiMate to a medical center in Peru. The innovative CO2 laser system has previously been purchased by hospitals in Hong Kong, Poland, Hungary and Romania. (See Sep 2014 newsletter) http://www.bio-light.co.il/wp-content/uploads/2015/08/PR-Peru-final.pdf

Israel’s XLVision Sciences manufactures the IOPtiMate CO2 laser treatment for severe Glaucoma sufferers.  The treatment has just made its first sale in Hong Kong.  (Warning the video – although only an animation – may be unsettling to some readers) http://www.bio-light.co.il/wp-content/uploads/2014/09/First-Sale-in-HK.pdf